Learn Details Of Digital Dose Inhaler Market, Key Manufacturers Are Glenmark Pharmaceuticals Ltd., Novartis International AG, Propeller Health, AstraZeneca Plc, Forecast Report 2022

Digital Dose Inhaler Industry 2017 Market Research Report is a professional and in-depth study on the current state of the Digital Dose Inhaler industry. The Digital Dose Inhaler market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.

Digital dose inhalers are widely known as digihalers or metered dose inhalers. These are user-friendly hand held medical device which instead of a pill or a capsule, gives a particular amount of medication to the lungs in small bursts of aerosol form. Digital dose inhalers enable patients to keep a track on the amount of dosage and the number of times the medicine has to be consumed. This system is projected to let healthcare professionals to keep a tab on the prescribed dedicated therapy regime and patients adhesion towards it. Apart from being user-friendly, patients can self-administer via inhalation process.

Request A Sample Copy Of Report@ https://www.qyresearchgroups.com/request-sample/424875

These inhalers are most commonly used in the treatment of chronic obstructive pulmonary disease (COPD), and several other respiratory diseases including asthma. Digihalers consist of a pressurized canister inside a plastic cage along with a mouthpiece attached.Usually, in a standard inhaler, the total number of medicine puffs is 120. Whereas, the digital one consists of a compact screen which shows the number of doses or puffs remaining in the inhaler.

Moreover, this exclusive feature assist patients in letting them know whether they have taken the medication or not. Digital dose inhalers generally carry bronchodilator, corticosteroids or an amalgamation of both depending on the severity of the treatment prescribed by the medical care professional. Nowadays, these inhalers are widely preferred as compared to the normal ones due to the portable size which makes it easier for the patient to carry it anywhere. Additionally, digital inhalers use a specific chemical propellant so as to eject the medication out of the inhaler.

The global dose inhaler market was worth more than USD 8393.4 million in 2015, and it estimated to reach approximately USD 3.56 billion by the end of 2024.The major market driving factors of this industry on a global level are more occurrence of chronic respiratory disorders like asthma, obstructive sleep apnea (OSA), Obstructive Pulmonary Disease (COPD), respiratory allergies and many others. In 2015, World Health Organization (WHO) estimated that nearly 6% of the death across the world happen due to COPD, attributing to more than 3 million individuals worldwide. The data further suggests that in 2015, over 90% of the mortality due to COPD happened in the middle and low income countries.

Complete report on Digital Dose Inhaler market report spread across 105 pages, profiling 7 companies and supported with tables and figures available@ https://www.qyresearchgroups.com/report/global-digital-dose-inhaler-market-research-report-2017-d-50

Moreover, the constantly increasing geriatric population suffering from both mild as well as severe respiratory disorders is mainly said to reinstate the need for such new generation inhalation devices and that in return is another primary factors responsible for the lucrative growth of this market industry on a global level.Numerous enhancements in technology is transforming the inhalation therapy devices that comprises of the digital dose inhalers which has an e-dose counter, compact inhalers and internet connected, amongst others which are impelling the market growth of digital dose inhalers.Globally, several medical device fabricators are ascendingly aiming towards the connectivity technologies to better the patient medication adhesion and to make sure that the dosage of the medicine is administered precisely.

The rising need for technology-enabled features which includes seamless data channeling and patient tracking are critical factors which are predicted to render a spur to the usage rates of such respiratory devices in the future. North America, was accountable for the maximum market share in 2015, i.e., 38.36%. This was due to excessive activities pertaining to research and development, along with increasing awareness about presently accessible hi-tech respiratory devices.

The key market players for the Global Digital Dose Inhaler Market are Opko Health, Inc., Glenmark Pharmaceuticals Ltd., Propeller Health, Novartis International AG, AstraZeneca Plc, Teva Pharmaceutical Industries Ltd and Philips Respironics. On the basis of product type, the global market industry is classified into; Metered Dose Inhaler and Dry Powder Inhaler. Based on end user application, the market industry is split into; Hospital, Clinics and Others. Geographically, the global market is segmented into regions which are; Southeast Asia, Asia-Pacific, North America and Europe.

About Us:
QY Research Groups is a company that simplifies how analysts and decision makers get industry data for their business. Our unique colossal technology has been developed to offer refined search capabilities designed to exploit the long tail of free market research whilst eliminating irrelevant results. QY Research Groups is the collection of market intelligence products and services on the Web. We offer reports and update our collection daily to provide you with instant online access to the world's most complete and current database of expert insights on Global industries, companies, products, and trends.

Connect Us@ sales@qyresearchgroups.com with subject line “Global Digital Dose Inhaler Market Research Report 2017 “ and your contact details to purchase this report or get your questions answered. OR Call Us @ +1-888-236-2744.

This release was published on openPR.